Tag: Medical and Dental Innovation Award

Claus Garbe | Medicine and Dentistry | Outstanding Scientist Award

Published on by World Science Awards

Outstanding Scientist Award

Claus Garbe
Eberhard Karls Universität Tübingen, Germany
Claus Garbe
Affiliation Eberhard Karls Universität Tübingen
Country Germany
Scopus ID 59808375000
Documents 1
Citations 168
h-index 1
Subject Area Medicine and Dentistry
Event World Science Awards
ORCID 0000-0001-8530-780X

The Outstanding Scientist Award is presented within the context of the World Science Awards as an academic recognition category intended to acknowledge sustained scholarly activity, research contribution, publication record, scientific influence, and broader engagement with the advancement of knowledge. This profile concerns Claus Garbe, affiliated with Eberhard Karls Universität Tübingen in Germany, whose scholarly record is represented through the Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. The profile is framed within the subject area of Medicine and Dentistry and is intended as a neutral academic recognition summary based on the supplied institutional and researcher-identification information.[1][2][3]

Abstract

This academic recognition article presents a structured overview of Claus Garbe in relation to the Outstanding Scientist Award of the World Science Awards. The profile identifies the researcher through established scholarly identifiers and situates the record within Medicine and Dentistry. Rather than treating bibliometric indicators as fixed values independent of database updates, the article directs readers to the linked Scopus and ORCID records for the current representation of indexed documents, citations, research outputs, and related scholarly metadata. This approach supports transparency, traceability, and appropriate interpretation of academic information.[1][2]

Keywords

Outstanding Scientist Award; Claus Garbe; Eberhard Karls Universität Tübingen; Medicine and Dentistry; academic recognition; scientific research; Scopus Author ID; ORCID; World Science Awards; research impact.

Introduction

Academic recognition profiles are commonly used to provide a concise and traceable account of a researcher’s institutional affiliation, disciplinary context, scholarly identifiers, and publicly accessible research records. Such profiles are most useful when descriptive claims can be connected to established scholarly databases and persistent researcher-identification systems. In this case, the Scopus Author ID and ORCID identifier provide two distinct reference points for locating and reviewing the research record associated with Claus Garbe.[1][2]

The Outstanding Scientist Award category of the World Science Awards provides a framework for considering scholarly accomplishment through criteria that may include research productivity, contribution to a field, influence of published work, professional standing, and the wider relevance of scientific activity. Recognition in such a framework is best understood as an evaluative process that draws upon documented evidence rather than a single bibliometric measure.[3]

Research Profile

Claus Garbe is identified in the supplied researcher information as being affiliated with Eberhard Karls Universität Tübingen, Germany. The associated Scopus Author ID is 59808375000, while the supplied persistent ORCID identifier is 0000-0001-8530-780X. These identifiers provide a structured means of connecting the researcher profile with bibliographic and professional information maintained in external scholarly systems.[1][2]

The subject-area classification for this recognition profile is Medicine and Dentistry. Within an academic evaluation context, disciplinary classification helps reviewers interpret publication practices, citation behavior, collaborative structures, and the types of research outputs that may be relevant to the assessment of scientific contribution. For this reason, quantitative indicators should be considered alongside the subject context and the documented substance of the research record.[1]

Research Contributions

Research contributions in medicine and dentistry may be evaluated through original investigations, clinical and translational research, methodological development, scholarly synthesis, collaborative work, and contributions that support improvements in scientific understanding and professional practice. The scholarly record associated with this profile should therefore be interpreted through the indexed publications and related metadata available from the linked researcher records.[1][2]

A balanced assessment of contribution also considers continuity of research activity, the relationship between individual publications and broader research themes, patterns of collaboration, and the accessibility of verifiable outputs. Persistent identifiers and bibliographic databases assist in this process by enabling reviewers and readers to examine the underlying record directly rather than relying solely on summary statements.[1][2]

Publications

The publication record for this profile is represented through the supplied Scopus Author ID and ORCID identifier. Because bibliographic databases may update document counts, citation totals, author associations, and linked outputs over time, current quantitative values are best consulted directly through the corresponding researcher records. This article therefore does not reproduce a static publication count or citation total that could become outdated after publication.[1][2]

Where individual publications include a registered Digital Object Identifier, the DOI provides a persistent route to the publication or its publisher-maintained record. Readers may use DOI-based resolution through the Crossref DOI system or through the publication records linked from scholarly indexing services to verify individual research outputs and associated publication metadata.[4]

Research Impact

Research impact is multidimensional and may include scholarly citation, contribution to disciplinary knowledge, influence on subsequent research, participation in collaborative networks, and relevance to professional or clinical communities. Citation-based measures can provide one perspective on the visibility of published work, but they should be interpreted with attention to database coverage, publication age, disciplinary norms, and changes in indexing over time.[1]

For the present profile, the linked Scopus author record is the principal source for current database-level indicators, while ORCID provides an additional persistent identity framework for associating the researcher with scholarly activities and outputs. Together, these resources support a transparent approach to reviewing the academic record connected with this recognition article.[1][2]

Award Suitability

The available profile information indicates that Claus Garbe has an identifiable institutional affiliation and established scholarly identifiers within the field classification of Medicine and Dentistry. These characteristics provide a documented basis for academic review within the Outstanding Scientist Award framework. Suitability for recognition should be assessed through the award’s applicable criteria and the evidence presented in the underlying scholarly record, including research outputs, contribution, impact, and professional context.[1][3]

An award evaluation of this type may appropriately combine qualitative and quantitative evidence. Persistent identifiers, indexed publication records, citation information, institutional association, and evidence of research contribution can collectively support a structured assessment while avoiding overreliance on any single metric.[1][2]

Conclusion

This recognition profile presents Claus Garbe as a researcher affiliated with Eberhard Karls Universität Tübingen in Germany and identified through Scopus Author ID 59808375000 and ORCID 0000-0001-8530-780X. Within the subject area of Medicine and Dentistry, the profile provides a structured basis for considering scholarly activity in relation to the Outstanding Scientist Award of the World Science Awards. Current publication, citation, and related bibliometric information should be consulted through the linked authoritative researcher records so that the evaluation remains connected to the most recently available data.[1][2][3]

References

  1. Elsevier. (n.d.). Scopus author details: Claus Garbe, Author ID 59808375000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59808375000
  2. ORCID. (n.d.). ORCID record: Claus Garbe, 0000-0001-8530-780X. ORCID.
    https://orcid.org/0000-0001-8530-780X
  3. World Science Awards. (n.d.). World Science Awards: academic recognition and award information.
    https://worldscienceawards.com/
  4. International DOI Foundation. (n.d.). The DOI System. Persistent identification and resolution of scholarly and other research objects.

Royston Liew | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623

 

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Published on by World Science Awards

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3